Three-time All-Star reliever Liam Hendriks is weighing multiple offers from interested clubs, reports ESPN’s Jeff Passan.
Hendriks, who’s recovering from Tommy John surgery and aiming to return to action around the trade deadline this season, has set a deadline of Thursday (Feb. 15) to sign with a team, per Passan. If he doesn’t sign by then — presumably meaning a team hasn't met whatever asking price he’s set — he’ll rehab on his own for the next several months and look to sign with a club closer to his return date.
Hendriks turned 35 on Feb. 10. His ascension from a fringe arm riding the DFA carousel back in 2013-15 to one of the sport’s premier relievers is one of the most remarkable turnarounds in recent memory. Hendriks was designated for assignment four times and placed on waivers without a public DFA on another occasion and traded in three different minor swaps along the way. In 2018, the A’s not only designated him for assignment for the fourth (and final) time in his career — they succeeded in passing Hendriks through waivers unclaimed.
Hendriks posted solid but unremarkable numbers as a low-leverage reliever for the A’s from 2016-18 but returned from that outright in 2019 as an entirely different pitcher. He scrapped his sinker, leaned far more heavily into a four-seamer that had jumped by more than 1.5 mph in average velocity, and became a two-pitch powerhouse who flummoxed opponents with his four-seamer/slider combo.
That devastating pair of pitches quickly catapulted Hendriks to the ranks of baseball’s elite bullpen arms. From 2019-22, he pitched 239 innings with 114 saves, an overwhelming 38.8% strikeout rate and a pristine 5.1% walk rate. In addition to his trio of All-Star nods, Hendriks twice won the Mariano Rivera American League Reliever of the Year Award and inked a huge three-year, $54M contract with the White Sox.
The 2023 season brought about a sobering bit of disheartening news, as Hendriks announced last offseason that he’d been diagnosed with non-Hodgkins lymphoma and would immediately embark on a wave of chemotherapy treatment. Just three and a half months later, Hendriks triumphantly announced that he was cancer-free. He began a rehab assignment in early May and returned to the majors on May 29 — remarkably less than four months after making his original announcement.
It was a feel-good story for White Sox fans amid a disastrous start to the season, but the good vibes didn’t last long. Hendriks was placed back on the injured list just two weeks later, this time due to inflammation in his right elbow. While the issue was initially believed to be relatively minor — Hendriks at first expressed optimism he’d be back in a matter of weeks — damage to his ulnar collateral ligament was either discovered shortly thereafter or developed over the course of his rehab. There’d been no prior public indication that surgery was even a consideration, but the Sox announced on Aug. 2 that Hendriks was slated for Tommy John surgery.
Hendriks’ track record is strong enough that he ought to be a clear candidate for a big league deal — likely a two-year arrangement that’ll allow him the opportunity to rehab with a team’s medical staff for the bulk of this season with an eye toward either a second-half return or a 2025 return. This type of contract is relatively common, though the fact that Hendriks is entering his age-35 season perhaps complicates the scenario to some extent.
There’s not a team in baseball that couldn’t use a healthy Hendriks in its bullpen. That won’t be an option until later in the season at the earliest and perhaps not until Opening Day 2025, depending on how his rehab progresses, but the track record alone should lead to plenty of interest.
More must-reads: